BYND

Business Context and Reporting Period

Company: Beyond Meat, Inc. (BYND)
Filing Type: Form 10-Q (Unaudited)
Period Ended: March 28, 2026 (Q1 2026)
Business Overview: Beyond Meat is a leading plant-based meat company currently executing a strategic repositioning to "Beyond The Plant Protein Company." This initiative aims to expand beyond core meat analogues into adjacent categories, including the recently launched "Beyond Immerse" functional beverage line. The company is navigating persistent category weakness, declining demand, and significant cost-reduction initiatives, including the cessation of operational activities in China in 2025.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Net revenues decreased 15.3% year-over-year to $58.2 million, driven primarily by a 19.5% decrease in volume sold. U.S. retail and foodservice channels saw significant declines, while international retail grew 8.1%.
• Margin Improvement: Gross margin improved from a loss of (10.1)% to a profit of 3.4%. This was driven by a 5.4% increase in net revenue per pound and a 7.6% decrease in cost of goods sold per pound, aided by lower inventory provisions and reduced manufacturing expenses.
• Operating Expense Reduction: Total operating expenses decreased 25.0% to $43.1 million. SG&A expenses dropped 24.2% due to lower marketing costs ($6.5 million reduction) and legal expenses ($4.0 million reduction).
• Debt Restructuring Impact: The company recognized a $6.1 million gain on debt extinguishment and an $11.9 million non-cash gain from the remeasurement of derivative liabilities related to its 2030 Notes. These items significantly reduced the net loss compared to the prior year.
• Inventory Correction: The Q1 2025 comparative figures were corrected for immaterial errors regarding inventory valuation and debt issuance costs, resulting in a restated net loss of $61.1 million for that period.

Guidance, Outlook, and Risks

• Strategic Repositioning: Management is pivoting to "Beyond The Plant Protein Company," launching new products like Beyond Immerse beverages. Success is not guaranteed and requires incremental investment in marketing and distribution.
• Liquidity and Capital Resources: The company has $191.0 million in unrestricted cash and $14.8 million in restricted cash. It has fully drawn its $100.0 million Delayed Draw Term Loan facility. The company no longer satisfies eligibility for Form S-3 and cannot access its ATM Program.
• Debt Obligations: Significant indebtedness includes 2030 Notes (7.00% PIK Toggle) and Delayed Draw Term Loans (12.0% PIK). The company recently remedied a technical default on its Loan and Security Agreement related to the late delivery of audited financial statements.
• Legal Contingencies:
  • Trademark Litigation: A jury verdict in Sonate v. Beyond Meat awarded $38.9 million in damages ($23.5M actual + $15.4M disgorgement). The company has accrued this amount and is pursuing post-trial motions.
  • Consumer Class Action: A $7.5 million settlement regarding protein labeling claims was finalized and paid in 2025.
  • Regulatory Risks: Ongoing uncertainty regarding the use of "meat" terminology in the EU and U.S. could impact marketing and labeling.
• Internal Controls: The company disclosed material weaknesses in internal controls over financial reporting related to non-routine transactions and inventory valuation. Remediation plans are underway, but controls were deemed ineffective as of March 28, 2026.

Investor Verification Checklist

• Cash Burn Rate: Verify the sustainability of the $191 million cash balance given the negative operating cash flow of $5.0 million in Q1 and the inability to access the ATM program.
• Debt Covenants: Monitor compliance with the $15.0 million minimum liquidity covenant and restrictions on cash interest payments under the Loan and Security Agreement and 2030 Notes.
• Legal Accruals: Track the status of the Sonate trademark litigation post-trial motions and potential appeals, which could impact the $38.9 million accrual.
• Inventory Valuation: Scrutinize future inventory provisions given the previously identified material weakness in inventory valuation controls and the history of write-downs.
• Strategic Execution: Assess early performance metrics of the "Beyond Immerse" beverage line and the "Beyond The Plant Protein Company" rebranding to determine if they can offset declining meat analogue sales.
• Dilution Risk: Monitor the conversion of 2030 Notes and exercise of warrants, which could lead to significant equity dilution.